Targeted intervention of eIF4A1 inhibits EMT and metastasis of pancreatic cancer cells via c-MYC/miR-9 signaling
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted intervention of eIF4A1 inhibits EMT and metastasis of pancreatic cancer cells via c-MYC/miR-9 signaling
Authors
Keywords
-
Journal
Cancer Cell International
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-12-14
DOI
10.1186/s12935-021-02390-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MYC as a Target for Cancer Treatment
- (2021) Michael J Duffy et al. CANCER TREATMENT REVIEWS
- Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc
- (2021) Sarah K. Madden et al. Molecular Cancer
- EIF4A3: a gatekeeper of autophagy
- (2021) Despoina Sakellariou et al. Autophagy
- Early detection of pancreatic cancer
- (2020) Stephen P Pereira et al. Lancet Gastroenterology & Hepatology
- Comprehensive analysis of KRAS variants in patients (pts) with pancreatic cancer (PDAC): Clinical/molecular correlations and real-world outcomes across standard therapies.
- (2020) Andrew Eugene Hendifar et al. JOURNAL OF CLINICAL ONCOLOGY
- Drugging “undruggable” genes for cancer treatment: Are we making progress?
- (2020) Michael J. Duffy et al. INTERNATIONAL JOURNAL OF CANCER
- A First-in-Human Phase I Study to Evaluate the ERK1/2 Inhibitor GDC-0994 in Patients with Advanced Solid Tumors
- (2019) Andrea Varga et al. CLINICAL CANCER RESEARCH
- Musashi2 contributes to the maintenance of CD44v6+ liver cancer stem cells via notch1 signaling pathway
- (2019) Xiju Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeting Protein Translation by Rocaglamide and Didesmethylrocaglamide to Treat MPNST and Other Sarcomas
- (2019) Long-Sheng Chang et al. MOLECULAR CANCER THERAPEUTICS
- Rocaglamide enhances NK cell-mediated killing of non-small cell lung cancer cells by inhibiting autophagy
- (2018) Chao Yao et al. Autophagy
- Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer
- (2018) Eric Van Cutsem et al. INTERNATIONAL JOURNAL OF CANCER
- Highly stable and efficient all-inorganic lead-free perovskite solar cells with native-oxide passivation
- (2018) Min Chen et al. Nature Communications
- Targeting prohibitins with chemical ligands inhibits KRAS-mediated lung tumours
- (2017) H Yurugi et al. ONCOGENE
- Yeast eIF4A enhances recruitment of mRNAs regardless of their structural complexity
- (2017) Paul Yourik et al. eLife
- Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor
- (2016) Shintaro Iwasaki et al. NATURE
- Inhibition of the CRAF/prohibitin interaction reverses CRAF-dependent resistance to vemurafenib
- (2016) N A Doudican et al. ONCOGENE
- Translational dysregulation in cancer: eIF4A isoforms and sequence determinants of eIF4A dependence
- (2015) F. Raza et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- MicroRNAs as regulators and mediators of c-MYC function
- (2015) Rene Jackstadt et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Targeting the eIF4F Translation Initiation Complex: A Critical Nexus for Cancer Development
- (2015) J. Pelletier et al. CANCER RESEARCH
- Organoid Models of Human and Mouse Ductal Pancreatic Cancer
- (2015) Sylvia F. Boj et al. CELL
- Targeting Translation Initiation Bypasses Signaling Crosstalk Mechanisms That Maintain High MYC Levels in Colorectal Cancer
- (2015) A. Wiegering et al. Cancer Discovery
- Targeting MYC Translation in Colorectal Cancer
- (2015) A. Castell et al. Cancer Discovery
- A Phase Ib Dose-Escalation Study of the Oral Pan-PI3K Inhibitor Buparlisib (BKM120) in Combination with the Oral MEK1/2 Inhibitor Trametinib (GSK1120212) in Patients with Selected Advanced Solid Tumors
- (2014) P. L. Bedard et al. CLINICAL CANCER RESEARCH
- Therapeutic Effects of an Anti-Myc Drug on Mouse Pancreatic Cancer
- (2014) Dimitris Stellas et al. JNCI-Journal of the National Cancer Institute
- Targeting the prohibitin scaffold-CRAF kinase interaction in RAS-ERK-driven pancreatic ductal adenocarcinoma
- (2014) Zhou Luan et al. Molecular Cancer
- Rocaglamide overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells by attenuating the inhibition of caspase-8 through cellular FLICE-like-inhibitory protein downregulation
- (2014) ZHOU LUAN et al. Molecular Medicine Reports
- eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies
- (2014) Lise Boussemart et al. NATURE
- Roles for KRAS in Pancreatic Tumor Development and Progression
- (2013) Marina Pasca di Magliano et al. GASTROENTEROLOGY
- Direct reprogramming by oncogenic Ras and Myc
- (2013) I. Ischenko et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EMT and Dissemination Precede Pancreatic Tumor Formation
- (2012) Andrew D. Rhim et al. CELL
- Endogenous Myc maintains the tumor microenvironment
- (2011) N. M. Sodir et al. GENES & DEVELOPMENT
- Myc-modulated miR-9 makes more metastases
- (2010) Yeesim Khew-Goodall et al. NATURE CELL BIOLOGY
- miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
- (2010) Li Ma et al. NATURE CELL BIOLOGY
- Canonical Initiation Factor Requirements of the Myc Family of Internal Ribosome Entry Segments
- (2009) K. A. Spriggs et al. MOLECULAR AND CELLULAR BIOLOGY
- c-Myc and eIF4F Are Components of a Feedforward Loop that Links Transcription and Translation
- (2008) C.-J. Lin et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started